These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2198784)

  • 1. PCP and hallucinogens.
    Carroll ME
    Adv Alcohol Subst Abuse; 1990; 9(1-2):167-90. PubMed ID: 2198784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse liability and behavioral toxicity assessment: progress report from the behavioral biology laboratories of the Johns Hopkins University School of Medicine.
    Brady JV; Griffiths RR; Hienz RD; Bigelow GE; Emurian HH; Lukas SE; Ator NA; Nellis MJ; Ray RL; Pearlson GD
    NIDA Res Monogr; 1984 Mar; 49():92-108. PubMed ID: 6148698
    [No Abstract]   [Full Text] [Related]  

  • 3. Phencyclidine dependence: the relationship of dose and serum concentrations to operant behavioral effects.
    Wessinger WD; Owens SM
    J Pharmacol Exp Ther; 1991 Jul; 258(1):207-15. PubMed ID: 2072296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phencyclidine abuse, dependence, intoxication, and psychosis].
    Koseki T; Nabeshima T
    Nihon Rinsho; 2010 Aug; 68(8):1511-5. PubMed ID: 20715485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated subchronic exposure to phencyclidine elicits excessive atypical grooming in rats.
    Audet MC; Goulet S; Doré FY
    Behav Brain Res; 2006 Feb; 167(1):103-10. PubMed ID: 16257455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine: pharmacologic and clinical review.
    Dove HW
    Psychiatr Med; 1984 Jun; 2(2):189-209. PubMed ID: 6400596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approaches and issues in non-clinical evaluation of abuse and dependence.
    Moser P; Wolinsky T; Castagné V; Duxon M
    J Pharmacol Toxicol Methods; 2011; 63(2):160-7. PubMed ID: 20868759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlimited access intravenous drug self-administration in rhesus monkeys.
    Balster RL; Woolverton WL
    Fed Proc; 1982 Feb; 41(2):211-5. PubMed ID: 7199481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral dependence upon phencyclidine and ketamine in the rat.
    Beardsley PM; Balster RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):203-11. PubMed ID: 3612525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs.
    Hardin JS; Wessinger WD; Proksch JW; Owens SM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1113-22. PubMed ID: 9618414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of acute and chronic phencyclidine on schedule-controlled behavior in the squirrel monkey.
    Chait LD; Balster RL
    J Pharmacol Exp Ther; 1978 Jan; 204(1):77-87. PubMed ID: 412949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of behavioral pharmacology research on phencyclidine.
    Balster RL
    NIDA Res Monogr; 1986; 64():148-62. PubMed ID: 3086731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of intravenous phencyclinoid self-administration.
    Marquis KL; Moreton JE
    Pharmacol Biochem Behav; 1987 Jun; 27(2):385-9. PubMed ID: 3628455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addictive behaviors and benzodiazepines: 2. Are there differences between benzodiazepines in potential for physical dependence and abuse liability?
    Senay EC
    Adv Alcohol Subst Abuse; 1990; 9(3-4):53-64. PubMed ID: 1981124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse liability of barbiturates and other sedative-hypnotics.
    Morgan WW
    Adv Alcohol Subst Abuse; 1990; 9(1-2):67-82. PubMed ID: 2198786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric sequelae of phencyclidine abuse.
    Fauman B; Aldinger G; Fauman M; Rosen P
    Clin Toxicol; 1976; 9(4):529-38. PubMed ID: 10126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Lynskey MT; Agrawal A
    Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.